Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steve Horvath is active.

Publication


Featured researches published by Steve Horvath.


Genetic Epidemiology | 2000

Implementing a unified approach to family-based tests of association.

Nan M. Laird; Steve Horvath; Xin Xu

We describe a broad class of family‐based association tests that are adjusted for admixture; use either dichotomous or measured phenotypes; accommodate phenotype‐unknown subjects; use nuclear families, sibships or a combination of the two, permit multiple nuclear families from a single pedigree; incorporate di‐ or multi‐allelic marker data; allow additive, dominant or recessive models; and permit adjustment for covariates and gene‐by‐environment interactions. The test statistic is the covariance between a user‐specified function of the genotype and a user‐specified function of the trait. The distribution of the statistic is computed using the appropriate conditional distribution of offspring genotypes that adjusts for admixture. Genet. Epidemiol. 19(Suppl 1):S36–S42, 2000.


American Journal of Human Genetics | 1998

A Discordant-Sibship Test for Disequilibrium and Linkage: No Need for Parental Data

Steve Horvath; Nan M. Laird

The sibship disequilibrium test (SDT) is designed to detect both linkage in the presence of association and association in the presence of linkage (linkage disequilibrium). The test does not require parental data but requires discordant sibships with at least one affected and one unaffected sibling. The SDT has many desirable properties: it uses all the siblings in the sibship; it remains valid if there are misclassifications of the affectation status; it does not detect spurious associations due to population stratification; asymptotically it has a chi2 distribution under the null hypothesis; and exact P values can be easily computed for a biallelic marker. We show how to extend the SDT to markers with multiple alleles and how to combine families with parents and data from discordant sibships. We discuss the power of the test by presenting sample-size calculations involving a complex disease model, and we present formulas for the asymptotic relative efficiency (which is approximately the ratio of sample sizes) between SDT and the transmission/disequilibrium test (TDT) for special family structures. For sib pairs, we compare the SDT to a test proposed both by Curtis and, independently, by Spielman and Ewens. We show that, for discordant sib pairs, the SDT has good power for testing linkage disequilibrium relative both to Curtiss tests and to the TDT using trios comprising an affected sib and its parents. With additional sibs, we show that the SDT can be more powerful than the TDT for testing linkage disequilibrium, especially for disease prevalence >.3.


American Journal of Human Genetics | 2000

The transmission/disequilibrium test and parental-genotype reconstruction for X-chromosomal markers

Steve Horvath; Nan M. Laird; Michael Knapp

Family-based association methods have recently been introduced that allow testing for linkage in the presence of linkage disequilibrium between a marker and a disease even if there is only incomplete parental-marker information. No such tests are currently available for X-linked markers. This report fills this methodological gap by presenting the X-linked sibling transmission/disequilibrium test (XS-TDT) and the X-linked reconstruction-combination transmission/disequilibrium test (XRC-TDT). As do their autosomal counterparts (S-TDT and RC-TDT), these tests make no assumption about the mode of inheritance of the disease and the ascertainment of the sample. They protect against spurious association due to population stratification. The two tests were compared by simulations, which show that (1) the X-linked RC-TDT is, in general, considerably more powerful than the X-linked S-TDT and (2) the lack of parental-genotype information can be offset by the typing of a sufficient number of sibling controls. A freely available SAS implementation of these tests allows the calculation of exact P values.


Epilepsy Research | 2000

No evidence for association between the KCNQ3 gene and susceptibility to idiopathic generalized epilepsy

Karsten Haug; Kerstin Hallmann; Steve Horvath; Thomas Sander; Christian Kubisch; Birgit Rau; Joern S. Dullinger; Stefan Beyenburg; Christian E. Elger; Peter Propping; Armin Heils

Idiopathic generalized epilepsy (IGE) comprises a heterogeneous group of disorders, in which a high genetic predisposition and a complex mode of inheritance have been suggested. Recent identification of ion channel gene mutations in Mendelian epileptic disorders suggests genetically driven neuronal hyperexcitability as one important factor in epileptogenesis. Mutations in two neuronal voltage-gated potassium channel genes (KCNQ2 and KCNQ3) have already been shown to cause epilepsy (BFNC), and we now tested the hypothesis that genetic variation in the KCNQ3 gene confers liability to common IGE subtypes. Length variation of two intragenic polymorphic markers (D8S558 and D8S1835) were therefore assessed in 71 nuclear families ascertained for an affected child. However, the transmission-disequilibrium-test did not show significant differences between the transmitted and non-transmitted parental alleles. Thus, our findings do not provide evidence that genetic variation in the KCNQ3 gene exerts a relevant effect in the etiology of common IGE subtypes.


Genetic Epidemiology | 2001

Genome wide linkage analysis in a general population sample using sigma(2)(A) random effects (SSARs) fitted by Gibbs sampling

Lyle J. Palmer; Kevin B. Jacobs; Katrina J. Scurrah; Xin Xu; Steve Horvath; Scott T. Weiss

We used variance components analysis to investigate the underlying determinants of the quantitative phenotypes (Q1–Q5) and their interrelationships in replicate 42 of the Genetic Analysis Workshop 12 simulated general population. Variance components models were fitted using Gibbs sampling in WinBUGS v1.3. Sigma‐squared‐A‐random‐effects (SSARs) were estimated for each phenotype, and were used as derived phenotypes in subsequent linkage analyses. Whole‐genome, multipoint linkage analyses were based upon a new Haseman‐Elston identity‐by descent sib‐pair method that takes a weighted combination of the trait‐sum and trait‐difference. The five quantitative traits simulated were closely correlated with each other and with affection status. The whole‐genome screen of quantitative traits associated with the simulated complex disease suggested that one or more major loci regulating Q1 localizes to chromosome 2p and that one or more major loci regulating Q5 may localize to chromosome Ip.


American Journal of Human Genetics | 2000

The Disequilibrium Maximum-Likelihood–Binomial Test Does Not Replace the Transmission/Disequilibrium Test

Steve Horvath; Christine Windemuth; Michael Knapp

To the Editor: n n nIn a previous issue of the Journal, Huang and Jiang (1999) introduced the disequilibrium maximum-likelihood–binomial test (DMLB) for affected-sibship data. The DMLB is supposed to combine the advantages of the mean test (Blackwelder and Elston 1985) and the transmission/disequilibrium test (TDT) (Terwilliger and Ott 1992; Spielman et al. 1993), in that the DMLB performs well when linkage disequilibrium (LD) is low and has power higher than or equal to that of the TDT when the LD ranges from moderate to strong. If this claim was correct, the TDT would be obsolete. In this letter, we show how to compute exact P values and exact critical values for the DMLB (and for the TDT), and we show that, when these exact critical values are used, the DMLB is never significantly more powerful than the TDT when there is complete LD. The opposite is true: the TDT is often significantly more powerful than the DMLB. Even when LD is at 80% of its maximum, the TDT still outperforms the DMLB when the marker- and disease-allele frequencies are identical. The asymptotic approximation used by Huang and Jiang (1999) can be inaccurate. We show that their choice of the critical value for the DMLB (cDMLB) is often anticonservative—that is, it violates the false-positive rate—whereas their choice of the critical value for the TDT (cTDT) tends to be overly conservative. The exact critical values depend on the number of heterozygous parents in the sample, and we are making available (contact the corresponding author) an SAS Institute (1990) program that computes exact critical values. Huang and Jiang (1999) introduce DMLB tests for two different cases of hypotheses. For the sake of brevity, we will focus only on the more important two-sided hypothesis, which is relevant when there is no prior knowledge about which marker allele is in LD with the disease. Let us give a brief description of the TDT and the DMLB for families with two affected children. Suppose that there are n2 heterozygous B1B2 parents in the data set. Let n22 denote the number of heterozygous parents who transmitted allele B1 to both children, let n21 denote the number of heterozygous parents who transmitted B1 to one child and B2 to the other child, and let n20 denote the number of heterozygous parents who transmitted B2 to both children. Then the TDT statistic is given by with an asymptotic χ21 distribution under the null hypothesis of no linkage. The score-statistic version of the DMLB is given by n n n n n nIncidentally, we note that equals the mean test for these data. Huang and Jiang (1999) show that, under the null hypothesis of no linkage, the DMLB has the asymptotic distribution .5χ21+.5χ22. They use this asymptotic distribution to compute the critical value cDMLB=17.38, corresponding to a false-positive rate of α=.0001. Similarly, under the null hypothesis of no linkage, the TDT has an asymptotic χ21 distribution, which can be used to show that, for the same false-positive rate, the critical value of the TDT is given by cTDT=15.14. These critical values are not ideal, as can be seen from table 1, which lists the exact error rates as a function of the number of heterozygous parents n2. Fortunately, one does not need to rely on asymptotic approximations, since, under the null hypothesis, one can easily compute exact P values for both tests. However, even if one is not interested in exact P values, one can easily compute the exact critical values that should be used, for families with two affected offspring, to maintain the correct type I error rate. The key observation for these calculations is that, under the null hypothesis, (n22,n21,n20) has a multinomial distribution with parameters n2 and (p2,p1,p0)=(.25,.5,.25), and the DMLB is a simple function of this low-dimensional distribution. These null distributions can be used to compute the exact critical values for both tests, some of which are listed in table 2. The critical values depend on the sample sizes, but there is no monotonous relationship between the number of heterozygous parents n2 and the critical values. Since interpolation between the different values of n2 is difficult, we are making available (contact the corresponding author) an SAS Institute (1990) program that calculates the critical values for both tests. n n n n nTable 1 n nExact Error Rates of the DMLB and the TDT Test Statistics When the Critical Values (Corresponding to α=.0001) Proposed by Huang and Jiang (1999) Are Used[Note] n n n n n nTable 2 n nExact Critical Values for the TDT and the DMLB Corresponding to α, as a Function of n2 n n n nTo compare the power of the two tests, we conducted simulation studies for the genetic models studied by Huang and Jiang (1999). We considered four genetic models: additive, dominant, multiplicative, and recessive. Let f0, f1, and f2 be the penetrances of disease genotypes dd, Dd, and DD, respectively, where D is the disease-causing allele. The relative genotypic risks (GRRs) are defined as r1=f1/f0 and r2=f2/f0. Like Huang and Jiang, we considered the following GRR values in the power calculation: (1) for the additive model, r1=4, r2=7; (2) for the dominant model, r1=4, r2=4; (3) for the multiplicative model, r1=4, r2=16; and (4) for the recessive model, r1=1, r2=4. We assumed that the biallelic marker and the disease loci are tightly linked (θ=0), and we studied two marker-allele frequencies m (.2 and .5) and three disease-allele frequencies p (.1, .2, and .5). We looked at four different values (1, .80, .50, and .30) of the normalized LD δp=Δ/Δmax, where Δ=P(B1D)-mp and . For each genetic model, we determined the approximate number of families N required to yield 80% power for the TDT (Knapp 1999). If N 1,000, then each sample was limited to 1,000 families. Both tests were evaluated for the same replicates. For each replicate, we determined the number n2 of heterozygous parents in the sample and then used it to compute exact critical values for both tests. Since both tests have a discrete distribution, we used a randomized test to reject at an exact false-positive rate of α=.0001. n nTable 3 lists the results of our simulation studies. When the marker-allele frequency equals the disease-allele frequency (m=p), the TDT has more power than the DMLB when δp⩾.8. Even when δp=.5, the DMLB is not consistently more powerful than the TDT. n n n nTable 3 n nComparison of the Power of the DMLB with That of the TDT, When α=.0001 n n n nWhen m≠p and δp=1, the TDT is more powerful than the DMLB in all but one case (multiplicative, p=.5, m=.2). However, when δp=.8, the DMLB is, “on average,” more powerful than the TDT. When δp⩽.5, the DMLB is usually more powerful than the TDT. However, in many cases in which the DMLB is significantly more powerful than the TDT, the required sample sizes are unrealistic (>1,000 families) anyway. Therefore, neither test would be useful in such a setting. n nWe conclude that, even though tests that can adapt to the degree of LD are a good idea, our simulations have shown that, if the degree of LD is strong (δp⩾.80), the DMLB usually is not more powerful than the TDT. For a candidate-gene study in which the typed marker affects the disease risk (i.e., m=p and δp=1), the TDT is preferable to the DMLB. In their study, Huang and Jiang (1999) showed that, when the LD is very weak, the mean test has more power than the DMLB. Therefore, the DMLB is most useful when there is moderate LD between marker and disease locus. Unfortunately, in practice, the amount of LD is usually unknown.


Genetic Epidemiology | 2001

Combining multiple phenotypic traits optimally for detecting linkage with sib-pair observations

Xin Xu; Lyle J. Palmer; Steve Horvath; L. J. Wei

A number of investigators have proposed regression methods for testing linkage between a phenotypic trait and a genetic marker with sib‐pair observations. Xu et al. [Am J Hum Genet 67:1025–8, 2000] studied a unified method for testing linkage, which tends to be more powerful than existing procedures. Often there are multiple traits, which are linked to a common set of genetic markers. In this paper, we present a simple generalization of the unified test to combine information from multiple traits optimally. We use the simulated Genetic Analysis Workshop 12 data to illustrate this methodology and show the advantage of using the combined tests over the single‐trait tests. For the four quantitative traits (Q1,...,Q4) studied, our linkage results suggest that major loci affecting Q1 and Q2 localize at or near markers D02G172, D19G032, and D09G122, while loci affecting Q3 and Q4 localize at or near markers D09G122 and D17G051.


Annals of Neurology | 2000

Interleukin‐1β gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis

Armin Heils; Karsten Haug; Wolfram S. Kunz; Guillén Fernández; Steve Horvath; Johannes Rebstock; Peter Propping; Christian E. Elger


Genetic Epidemiology | 2001

Family-based association test method: Age of onset traits and covariates

Steve Horvath; E Wei; Xin Xu; Lyle J. Palmer; M Baur


Wiley StatsRef: Statistics Reference Online | 2014

Family‐based association for quantitative traits.

Steve Horvath; Nan M. Laird

Collaboration


Dive into the Steve Horvath's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xin Xu

Southern Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge